The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Diagnostics of Inflammatory Bowel Disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,169
Self-citationInfliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Rutgeerts, P., Sandborn, W. J., Feagan, B. G., Reinisch, W., Olson, A., Johanns, J., Travers, S., Rachmilewitz, D., Hanauer, S. B., Lichtenstein, G. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050516 · Cited by 3,902
Development of a Crohn's Disease Activity Index
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80163-1 · Cited by 3,152
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · PubMed · Cited by 3,147
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis
Schroeder, K. W., Tremaine, W. J., & Ilstrup, D. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712243172603 · Cited by 3,026
Hampe, J., Franke, A., Rosenstiel, P., Till, A., Teuber, M., Huse, K., Albrecht, M., Mayr, G., De La Vega, F. M., Briggs, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1954 · Cited by 1,897
Self-citationProtein biomarker discovery and validation: the long and uncertain path to clinical utility
Rifai, N., Gillette, M. A., & Carr, S. A. (2006) · Nature Biotechnology · doi:10.1038/nbt1235 · Cited by 1,867
Rioux, J. D., Xavier, R. J., Taylor, K. D., Silverberg, M. S., Goyette, P., Huett, A., Green, T., Kuballa, P., Barmada, M. M., Datta, L. W., et al. (2007) · Nature Genetics · doi:10.1038/ng2032 · Cited by 1,769
Weinshilboum, R. M., & Sladek, S. L. (1980) · PubMed · Cited by 1,195
the Wellcome Trust Case Control Consortium, Parkes, M., Barrett, J. C., Prescott, N. J., Tremelling, M., Anderson, C. A., Fisher, S. A., Roberts, R. G., Nimmo, E. R., Cummings, F. R., et al. (2007) · Nature Genetics · doi:10.1038/ng2061 · Cited by 1,155
Hampe, J., Cuthbert, A., Croucher, P. J., Mirza, M. M., Mascheretti, S., Fisher, S., Frenzel, H., King, K., Hasselmeyer, A., MacPherson, A. J., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05063-7 · Cited by 1,092
Self-citationRachmilewitz, D. (1989) · BMJ · doi:10.1136/bmj.298.6666.82 · Cited by 1,039
Natalizumab Induction and Maintenance Therapy for Crohn's Disease
Sandborn, W. J., Colombel, J. F., Enns, R., Feagan, B. G., Hanauer, S. B., Lawrance, I. C., Panaccione, R., Sanders, M., Schreiber, S., Targan, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043335 · Cited by 927
Self-citationMary, J. Y., & Modigliani, R. (1989) · Gut · doi:10.1136/gut.30.7.983 · Cited by 884
Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo
Kiesslich, R., Burg, J., Vieth, M., Gnaendiger, J., Enders, M., Delaney, P., Polglase, A., McLaren, W., Janell, D., Thomas, S., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.06.050 · Cited by 843
Bacterial flagellin is a dominant antigen in Crohn disease
Lodes, M. J., Cong, Y., Elson, C. O., Mohamath, R., Landers, C. J., Targan, S. R., Fort, M., & Hershberg, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420295 · Cited by 802
HOLLANDER, D., VADHEIM, C. M., BRETTHOLZ, E., PETERSEN, G. M., DELAHUNTY, T., & ROTTER, J. I. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-6-883 · Cited by 760
Tibble, J. A., Sigthorsson, G., Bridger, S., Fagerhol, M. K., & Bjarnason, I. (2000) · Gastroenterology · doi:10.1053/gast.2000.8523 · Cited by 759
Yates, C. R., Krynetski, E. Y., Loennechen, T., Fessing, M. Y., Tai, H.-L., Pui, C.-H., Relling, M. V., & Evans, W. E. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-8-199704150-00003 · Cited by 756
D'Haens, G., Van Deventer, S., Van Hogezand, R., Chalmers, D., Kothe, C., Baert, F., Braakman, T., Schaible, T., Geboes, K., & Rutgeerts, P. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70005-3 · Cited by 745
Clinical, biological, and endoscopic picture of attacks of Crohn's disease
Modigliani, R., Mary, J.-Y., Simon, J.-F., Cortot, A., Soule, J.-C., Gendre, J.-P., & Rene, E. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90002-i · Cited by 699
Treatment of Ulcerative Colitis with a Humanized Antibody to the α 4 β 7 Integrin
Feagan, B. G., Greenberg, G. R., Wild, G., Fedorak, R. N., Paré, P., McDonald, J. W. D., Dubé, R., Cohen, A., Steinhart, A. H., Landau, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042982 · Cited by 692
Assessment of the Neutrophil Dominating Protein Calprotectin in Feces: A Methodologic Study
RØseth, A. G., Fagerhol, M. K., Aadland, E., & Schjønsby, H. (1992) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529209011186 · Cited by 669
Colombel, J., Ferrari, N., Debuysere, H., Marteau, P., Gendre, J., Bonaz, B., Soulé, J.-C., Modigliani, R., Touze, Y., Catala, P., et al. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70354-4 · Cited by 619
Schwartz, D. A., Wiersema, M. J., Dudiak, K. M., Fletcher, J. G., Clain, J. E., Tremaine, W. J., Zinsmeister, A. R., Norton, I. D., Boardman, L. A., Devine, R. M., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.28676 · Cited by 575
Libioulle, C., Louis, E., Hansoul, S., Sandor, C., Farnir, F., Franchimont, D., Vermeire, S., Dewit, O., de Vos, M., Dixon, A., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030058 · Cited by 560
Costa, F., Mumolo, M. G., Ceccarelli, L., Bellini, M., Romano, M. R., Sterpi, C., Ricchiuti, A., Marchi, S., & Bottai, M. (2005) · Gut · doi:10.1136/gut.2004.043406 · Cited by 550
Orchard, T. R., Wordsworth, B. P., & Jewell, D. P. (1998) · Gut · doi:10.1136/gut.42.3.387 · Cited by 549
Triester, S. L., Leighton, J. A., Leontiadis, G. I., Gurudu, S. R., Fleischer, D. E., Hara, A. K., Heigh, R. I., Shiff, A. D., & Sharma, V. K. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00506.x · Cited by 545
Kiesslich, R., Goetz, M., Lammersdorf, K., Schneider, C., Burg, J., Stolte, M., Vieth, M., Nafe, B., Galle, P. R., & Neurath, M. F. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.01.048 · Cited by 531
(2007) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31805563f3 · Cited by 529
Mow, W. S., Vasiliauskas, E. A., Lin, Y.-C., Fleshner, P. R., Papadakis, K. A., Taylor, K. D., Landers, C. J., Abreu-Martin, M. T., Rotter, J. I., Yang, H., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.015 · Cited by 517
Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin
Steinbakk, M., Naess-Andresen, C.-F., Fagerhol, M. K., Lingaas, E., Dale, I., & Brandtzaeg, P. (1990) · The Lancet · doi:10.1016/0140-6736(90)93237-j · Cited by 514
Lazenby, A. J., Yardley, J. H., Giardiello, F. M., Jessurun, J., & Bayless, T. M. (1989) · Human Pathology · doi:10.1016/0046-8177(89)90198-6 · Cited by 495
A simple method for assessing intestinal inflammation in Crohn's disease
Tibble, J., Teahon, K., Thjodleifsson, B., Roseth, A., Sigthorsson, G., Bridger, S., Foster, R., Sherwood, R., Fagerhol, M., & Bjarnason, I. (2000) · Gut · doi:10.1136/gut.47.4.506 · Cited by 492
Targan, S. R., Landers, C. J., Yang, H., Lodes, M. J., Cong, Y., Papadakis, K. A., Vasiliauskas, E., Elson, C. O., & Hershberg, R. M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.046 · Cited by 476
Genetic variation in DLG5 is associated with inflammatory bowel disease
Stoll, M., Corneliussen, B., Costello, C. M., Waetzig, G. H., Mellgard, B., Koch, W. A., Rosenstiel, P., Albrecht, M., Croucher, P. J. P., Seegert, D., et al. (2004) · Nature Genetics · doi:10.1038/ng1345 · Cited by 469
Self-citationLanders, C. J., Cohavy, O., Misra, R., Yang, H., Lin, Y., Braun, J., & Targan, S. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.35379 · Cited by 440
Diagnostic Precision of Fecal Calprotectin for Inflammatory Bowel Disease and Colorectal Malignancy
von Roon, A. C., Karamountzos, L., Purkayastha, S., Reese, G. E., Darzi, A. W., Teare, J. P., Paraskeva, P., & Tekkis, P. P. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01126.x · Cited by 401
Inflammation and Coagulation in Inflammatory Bowel Disease: The Clot Thickens
Danese, S., Papa, A., Saibeni, S., Repici, A., Malesci, A., & Vecchi, M. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00943.x · Cited by 384
Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease
Ruemmele, F. M., Targan, S. R., Levy, G., Dubinsky, M., Braun, J., & Seidman, E. G. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70252-5 · Cited by 379
Peeters, M., Joossens, S., Vermeire, S., Vlietinck, R., Bossuyt, X., & Rutgeerts, P. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03613.x · Cited by 344
Preoperative MR Imaging of Anal Fistulas: Does It Really Help the Surgeon?
Beets-Tan, R. G. H., Beets, G. L., van der Hoop, A. G., Kessels, A. G. H., Vliegen, R. F. A., Baeten, C. G. M. I., & van Engelshoven, J. M. A. (2001) · Radiology · doi:10.1148/radiology.218.1.r01dc0575 · Cited by 338
Chiu, H.-M., Chang, C.-Y., Chen, C.-C., Lee, Y.-C., Wu, M.-S., Lin, J.-T., Shun, C.-T., & Wang, H.-P. (2007) · Gut · doi:10.1136/gut.2006.099614 · Cited by 324
Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?
Rutgeerts, P., Vermeire, S., & Van Assche, G. (2007) · Gut · doi:10.1136/gut.2005.088732 · Cited by 321
Olesen, M., Eriksson, S., Bohr, J., Järnerot, G., & Tysk, C. (2004) · Gut · doi:10.1136/gut.2003.014431 · Cited by 316
Is small intestinal permeability really increased in relatives of patients with Crohn's disease?
May, G. R., Sutherland, L. R., & Meddings, J. B. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90638-s · Cited by 314
Genetics of Crohn disease, an archetypal inflammatory barrier disease
Schreiber, S., Rosenstiel, P., Albrecht, M., Hampe, J., & Krawczak, M. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1607 · Cited by 307
Self-citationRole of US in Detection of Crohn Disease: Meta-Analysis
Fraquelli, M., Colli, A., Casazza, G., Paggi, S., Colucci, A., Massironi, S., Duca, P., & Conte, D. (2005) · Radiology · doi:10.1148/radiol.2361040799 · Cited by 307
SULPHASALAZINE AND SALICYLAZOSULPHADIMIDINE IN ULCERATIVE COLITIS
Baron, J. H., Connell, A. M., Lennard-Jones, J. E., & Avery Jones, F. (1962) · The Lancet · doi:10.1016/s0140-6736(62)92080-9 · Cited by 287
Dubinsky, M. C., Lin, Y.-C., Dutridge, D., Picornell, Y., Landers, C. J., Farrior, S., Wrobel, I., Quiros, A., Vasiliauskas, E. A., Grill, B., et al. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00456.x · Cited by 286
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease
Collins, P. D., Mpofu, C., Watson, A. J., & Rhodes, J. M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000279.pub3 · Cited by 280
Brooker, J. C., Saunders, B. P., Shah, S. G., Thapar, C. J., Thomas, H. J. W., Atkin, W. S., Cardwell, C. R., & Williams, C. B. (2002) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(02)70034-5 · Cited by 274
Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis
Ghosh, S., Cowen, S., Hannan, W. J., & Ferguson, A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90227-5 · Cited by 267
Reese, G. E., Constantinides, V. A., Simillis, C., Darzi, A. W., Orchard, T. R., Fazio, V. W., & Tekkis, P. P. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00840.x · Cited by 267
Meta‐analysis: cancer risk of low‐grade dysplasia in chronic ulcerative colitis
THOMAS, T., ABRAMS, K. A., ROBINSON, R. J., & MAYBERRY, J. F. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03241.x · Cited by 266
Zholudev, A., Zurakowski, D., Young, W., Leichtner, A., & Bousvaros, A. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40369.x · Cited by 259
Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease
Schreiber, S., Nikolaus, S., Hampe, J., Hämling, J., Koop, I., Groessner, B., Lochs, H., & Raedler, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)03339-x · Cited by 252
Self-citationSpondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association.
K, D. V., Mielants, H., Cuvelier, C. A., De Keyser, F., Veys, E. M., & De Vos, M. (2000) · PubMed · Cited by 247
Thiopurine methyltransferase alleles in British and Ghanaian populations
Ameyaw, M. M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.2.367 · Cited by 240
Parente, F., Greco, S., Molteni, M., Anderloni, A., Sampietro, G. M., Danelli, P. G., Bianco, R., Gallus, S., & Bianchi Porro, G. (2004) · Gut · doi:10.1136/gut.2004.041038 · Cited by 216
Identification of a novel bacterial sequence associated with Crohn's disease
Sutton, C. L., Kim, J., Yamane, A., Dalwadi, H., Wei, B., Landers, C., Targan, S. R., & Braun, J. (2000) · Gastroenterology · doi:10.1053/gast.2000.8519 · Cited by 215
Raelson, J. V., Little, R. D., Ruether, A., Fournier, H., Paquin, B., Van Eerdewegh, P., Bradley, W. E. C., Croteau, P., Nguyen-Huu, Q., Segal, J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706645104 · Cited by 213
Self-citationOcular Manifestations of Inflammatory Bowel Disease
Mintz, R., Feller, E. R., Bahr, R. L., & Shah, S. A. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200403000-00012 · Cited by 211
Standaert–Vitse, A., Jouault, T., Vandewalle, P., Mille, C., Seddik, M., Sendid, B., Mallet, J., Colombel, J., & Poulain, D. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.009 · Cited by 210
NOD2/CARD15 does not influence response to infliximab in Crohn's disease
Vermeire, S., Louis, E., Rutgeerts, P., De Vos, M., Van Gossum, A., Belaiche, J., Pescatore, P., Fiasse, R., Pelckmans, P., Vlietinck, R., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.34172 · Cited by 208
Palm, Ø., Moum, B. A., Ongre, A. A., et al. (2002) · PubMed · Cited by 207
Crohn's disease--occurrence, course and prognosis. An epidemiologic cohort-study.
Munkholm, P. S. (1997) · PubMed · Cited by 197
Maconi, G., Parente, F., Bollani, S., Cesana, B. M., & Porro, G. B. (1996) · PubMed · Cited by 190
Influence of treatment on morphological features of mucosal inflammation
Geboes, K., & Dalle, I. (2002) · Gut · doi:10.1136/gut.50.suppl_3.iii37 · Cited by 166
The effect of elemental diet on intestinal permeability and inflammation in Crohn's disease
Teahon, K., Smethurst, P., Pearson, M., Levi, A. J., & Bjarnason, I. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90463-u · Cited by 163
Comparative proteomic studies on the pathogenesis of human ulcerative colitis
Hsieh, S., Shih, T., Yeh, C., Lin, C., Chou, Y.-Y., & Lee, Y. (2006) · PROTEOMICS · doi:10.1002/pmic.200500541 · Cited by 160
Lymphocytic colitis: clinical features, treatment, and outcomes
Pardi, D. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)05447-3 · Cited by 159
Diagnosis of fistulae and sinus tracts in patients with Crohn disease: value of MR imaging
Koelbel, G., Schmiedl, U., Majer, M., Weber, P., Jenss, H., Kueper, K., & Hess, C. (1989) · American Journal of Roentgenology · doi:10.2214/ajr.152.5.999 · Cited by 158
Winter, J., Walker, A. W., Shapiro, D., Gaffney, D., Spooner, R. J., & Mills, P. R. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02124.x · Cited by 157
Mascheretti, S., Hampe, J., Croucher, P. J. P., Nikolaus, S., Andus, T., Schubert, S., Olson, A. D., Bao, W., Fölsch, U. R., & Schreiber, S. (2002) · Pharmacogenetics · doi:10.1097/00008571-200210000-00002 · Cited by 156
Self-citationOffner, F. A., Jao, R. V., Lewin, K. J., Havelec, L., & Weinstein, W. M. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90122-3 · Cited by 148
Broomé, U., Glaumann, H., Hellers, G., Nilsson, B., Sörstad, J., & Hultcrantz, R. (1994) · Gut · doi:10.1136/gut.35.1.84 · Cited by 147
Primary Sclerosing Cholangitis
Talwalkar, J. A., & Lindor, K. D. (2005) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200501000-00009 · Cited by 137
Dorer, R. K., & Odze, R. D. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213268.30468.b4 · Cited by 137
Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling
Meuwis, M., Fillet, M., Geurts, P., de Seny, D., Lutteri, L., Chapelle, J.-P., Bours, V., Wehenkel, L. A., Bélaïche, J., Malaise, M., et al. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.12.019 · Cited by 133
Devlin, S. M., Yang, H., Ippoliti, A., Taylor, K. D., Landers, C. J., Su, X., Abreu, M. T., Papadakis, K. A., Vasiliauskas, E. A., Melmed, G., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.11.013 · Cited by 117
Anti-flagellin (CBir1) phenotypic and genetic Crohnʼs disease associations
Papadakis, K. A., Yang, H., Ippoliti, A., Mei, L., Elson, C. O., Hershberg, R. M., Vasiliauskas, E. A., Fleshner, P. R., Abreu, M. T., Taylor, K. D., et al. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20106 · Cited by 114
Sonographic evaluation of inflammatory bowel disease: a prospective, blinded, comparative study
Bremner, A. R., Griffiths, M., Argent, J. D., Fairhurst, J. J., & Beattie, R. M. (2006) · Pediatric Radiology · doi:10.1007/s00247-006-0245-8 · Cited by 113
Positron Emission Tomography in the Investigation of Pediatric Inflammatory Bowel Disease
Lemberg, D. A., Issenman, R. M., Cawdron, R., Green, T., Mernagh, J. R., Skehan, S. J., Nahmias, C., & Jacobson, K. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000172810.49619.cb · Cited by 109
Natural History and Clinical Behavior of Crohn's Disease Extending Beyond Two Decades
Freeman, H. J. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200309000-00005 · Cited by 105
Granulomas Do Not Affect Postoperative Recurrence Rates in Crohn's Disease
Wolfson, D. M., Sachar, D. B., Cohen, A. M., et al. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80336-3 · Cited by 93
Yui, S., Mikami, M., & Yamazaki, M. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.58.6.650 · Cited by 92
Interventions for treating lymphocytic colitis
Chande, N., Yatama, N. A., Bhanji, T., Nguyen, T. M., McDonald, J. W., & MacDonald, J. K. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006096.pub4 · Cited by 87
Till, A., Rosenstiel, P. C., Krippner‐Heidenreich, A., Mascheretti-Croucher, S., Croucher, P. J. P., Schäfer, H., Scheurich, P., Seegert, D., & Schreiber, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411541200 · Cited by 86
Self-citationRiis, L. B., Vind, I., Vermeire, S., Wolters, F. J., Katsanos, K., Politi, P., Freitas, J., Mouzas, I., O'Morain, C. A., Ruiz-Ochoa, V., et al. (2006) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20047 · Cited by 86
Papp, M., Altorjay, I., Norman, G. L., Shums, Z., Palatka, K., Vitális, Z., Földi, I., Lakos, G., Tumpek, J., Udvardy, M., et al. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20146 · Cited by 79
Makharia, G. K., Sachdev, V., Gupta, R., Lal, S., & Pandey, R. M. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9527-0 · Cited by 76
Anti-neutrophil antibodies in primary sclerosing cholangitis
Terjung, B., & Worman, H. J. (2001) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2001.0209 · Cited by 75
Non-invasive Evaluation of Activity in Inflammatory Bowel Disease by Power Doppler Sonography*
Heyne, R., Rickes, S., Bock, P. R., Schreiber, S., Wermke, W., & Lochs, H. H. (2002) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2002-22325 · Cited by 73
Self-citation111Indium autologous granulocytes in the detection of inflammatory bowel disease.
Saverymuttu, S. H., Peters, A. M., Crofton, M. E., Rees, H. C., Lavender, J. P., Hodgson, H. J. F., & CHADWICK, V. S. (1985) · Gut · doi:10.1136/gut.26.9.955 · Cited by 73
Yui, S., Mikami, M., Tsurumaki, K., & Yamazaki, M. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.61.1.50 · Cited by 71
Schreiber, S., Reinisch, W., Colombel, J. F., Sandborn, W. J., Hommes, D. W., Li, J., Kent, J. D., & Pollack, P. (2007) · Journal of Crohn s and Colitis Supplements · doi:10.1016/s1873-9954(07)70190-8 · Cited by 70
Self-citationAndersen, K., Vogt, C., Blondin, D., Beck, A., Heinen, W., Aurich, V., Häussinger, D., Mödder, U., & Cohnen, M. (2005) · European Journal of Radiology · doi:10.1016/j.ejrad.2005.11.004 · Cited by 69
Anti-outer membrane of porin C and anti-I2 antibodies in indeterminate colitis
Joossens, S. B. A., Colombel, J. F., Landers, C. J., Poulain, D., Geboes, K. J., Bossuyt, X., Targan, S. R., Rutgeerts, P., & Reinisch, W. (2006) · Gut · doi:10.1136/gut.2005.089623 · Cited by 68
Ainsworth, M. A., Eriksen, J., Rasmussen, J. W., & de Muckadell, O. B. S. (1989) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528909089246 · Cited by 67
Preventing Toxicity With a Gene Test
Marshall, E. (2003) · Science · doi:10.1126/science.302.5645.588 · Cited by 65
Increased gastric and intestinal permeability in patients with Crohn's disease.
Wyatt, J., Oberhuber, G., Pongratz, S., Püspök, A., Moser, G., Novacek, G., Lochs, H. H., & Vogelsang, H. (1997) · PubMed · Cited by 65
Diagnosis of Colitis: Making the Initial Diagnosis
Abreu, M. T., & Harpaz, N. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.12.032 · Cited by 54
Olives, J. P., Breton, A. L., Hugot, J., Oksman, F., Johannet, C., Ghisolfi, J., Navarro, J., & Cézard, J. (1997) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-199708000-00003 · Cited by 51
Relevance of serologic studies in inflammatory bowel disease
Vernier, G., Sendid, B., Poulain, D., & Colombel, J. (2004) · Current Gastroenterology Reports · doi:10.1007/s11894-004-0070-x · Cited by 47
Analysis of NOD2-mediated Proteome Response to Muramyl Dipeptide in HEK293 Cells
Weichart, D. H., Gobom, J., Klopfleisch, S., Häsler, R., Gustavsson, N., Billmann-Born, S., Lehrach, H. R., Seegert, D., Schreiber, S., & Rosenstiel, P. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505986200 · Cited by 47
Self-citationEffects of Human Calprotectin (L1) on In Vitro Immunoglobulin Synthesis
Brun, J. G., Ulvestad, E., Fagerhol, M. K., & Jonsson, R. (1994) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1994.tb03523.x · Cited by 47
Antibodies to Saccharomyces cerevisiae in Crohnʼs disease
Dassopoulos, T., Frangakis, C., Cruz-Correa, M. R., Talor, M. V., Burek, L. C., Datta, L. W., Nouvet, F. J., Bayless, T. M., & Brant, S. R. (2006) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20031 · Cited by 43
Berndt, U., Bartsch, S., Philipsen, L., Danese, S., Wiedenmann, B., Dignass, A. U., Hämmerle, M., & Sturm, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.295 · Cited by 40
Kitchen, P. A., Levi, A. J., Domizio, P., et al. (2002) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200211000-00007 · Cited by 32
Santhanagopalan, V., Hahn, B. L., & Sohnle, P. G. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.5.1289 · Cited by 31
Hepatobiliary disease in inflammatory bowel disease
Ahmad, J., & Slivka, A. (2002) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(01)00020-6 · Cited by 27
Heuman, R., Sjödahl, R., & Tagesson, C. (1982) · PubMed · Cited by 20
Genetic Testing in Crohn Disease: Utility in Individualizing Patient Management
Mascheretti, S., & Schreiber, S. (2005) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200505040-00002 · Cited by 17
Self-citationBraun, J. G., & Targan, S. R. (2006) · Advances in experimental medicine and biology · doi:10.1007/0-387-33778-4_13 · Cited by 10
Cited by
Kaser, A., Lee, A.-H., Franke, A., Glickman, J. N., Zeissig, S., Tilg, H., Nieuwenhuis, E. E. S., Higgins, D. E., Schreiber, S., Glimcher, L. H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.021 · Cited by 1,411
Self-citationDanese, S., & Fiocchi, C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1102942 · Cited by 1,102
Definition of Phenotypic Characteristics of Childhood-Onset Inflammatory Bowel Disease
Van Limbergen, J., Russell, R. K., Drummond, H. E., Aldhous, M. C., Round, N. K., Nimmo, E. R., Smith, L., Gillett, P. M., McGrogan, P., Weaver, L. T., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.06.081 · Cited by 949
A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease
Saeid Seyedian, S., Alimentary Tract Research Center, A. J. U. O. M. S., Nokhostin, F., Faculty of Medicine, A. J. U. O. M. S., Forogh Nokhostin, A. P. O. I. M., Dargahi Malamir, M., & Faculty of Medicine, M. D. O. I. M. (2019) · Journal of Medicine and Life · doi:10.25122/jml-2018-0075 · Cited by 817
European evidence based consensus for endoscopy in inflammatory bowel disease
Annese, V., Daperno, M., Rutter, M. D., Amiot, A., Bossuyt, P., East, J., Ferrante, M., Götz, M., Katsanos, K. H., Kießlich, R., et al. (2013) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2013.09.016 · Cited by 815
Metadata
- Authors
- Nikolaus, S., & Schreiber, S.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 133
- Issue
- 5
- Pages
- 1670-1689
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2141670388
- Cited by
- 430
- References
- 120
- FWCI
- 13.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.